Species identification of Mycobacterium abscessus subsp. abscessus and Mycobacterium abscessus subsp. bolletii using rpoB and hsp65, and susceptibility testing to eight antibiotics.

[1]  E. Böttger,et al.  Phylogeny of the Mycobacterium chelonae-like organism based on partial sequencing of the 16S rRNA gene and proposal of Mycobacterium mucogenicum sp. nov. , 1995, International journal of systematic bacteriology.

[2]  Robert Horsburgh,et al.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. , 2007, American journal of respiratory and critical care medicine.

[3]  J. Gaillard,et al.  Assessment of Clarithromycin Susceptibility in Strains Belonging to the Mycobacterium abscessus Group by erm(41) and rrl Sequencing , 2010, Antimicrobial Agents and Chemotherapy.

[4]  M. Sharifdini,et al.  Comparison of six simple methods for extracting ribosomal and mitochondrial DNA from Toxocara and Toxascaris nematodes. , 2013, Experimental parasitology.

[5]  R. Zarivach,et al.  23S rRNA base pair 2057-2611 determines ketolide susceptibility and fitness cost of the macrolide resistance mutation 2058A-->G. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[6]  C. Daley,et al.  Pulmonary non-tuberculous mycobacterial infections. , 2010, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[7]  J. Poehlsgaard,et al.  The structural basis of macrolide-ribosome binding assessed using mutagenesis of 23S rRNA positions 2058 and 2059. , 2004, Journal of molecular biology.

[8]  D. Griffith.  Nontuberculous mycobacterial lung disease , 2010, Current opinion in infectious diseases.

[9]  Y. Kook,et al.  Outbreak of Mycobacterium massiliense Infection Associated with Intramuscular Injections , 2007, Journal of Clinical Microbiology.

[10]  R. Wallace,,et al.  Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus , 1996, Antimicrobial agents and chemotherapy.

[11]  Young Kil Park,et al.  Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus. , 2011, American journal of respiratory and critical care medicine.

[12]  E. Böttger,et al.  Two-laboratory collaborative study on identification of mycobacteria: molecular versus phenotypic methods , 1996, Journal of clinical microbiology.

[13]  R. Wallace,,et al.  A Novel Gene, erm(41), Confers Inducible Macrolide Resistance to Clinical Isolates of Mycobacterium abscessus but Is Absent from Mycobacterium chelonae , 2008, Antimicrobial Agents and Chemotherapy.

[14]  C. Barry,et al.  Comment on: Identification of antimicrobial activity among FDA-approved drugs for combating Mycobacterium abscessus and Mycobacterium chelonae. , 2012, The Journal of antimicrobial chemotherapy.

[15]  R. Kroppenstedt,et al.  Mycobacterium hassiacum sp. nov., a new rapidly growing thermophilic mycobacterium. , 1997, International journal of systematic bacteriology.

[16]  E. Böttger,et al.  Structural basis for selectivity and toxicity of ribosomal antibiotics , 2001, EMBO reports.

[17]  M. Mendoza-Aguilar,et al.  The use of the microplate alamar blue assay (MABA) to assess the susceptibility of Mycobacterium lepraemurium to anti-leprosy and other drugs , 2012, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[18]  E. Tortoli.  Impact of Genotypic Studies on Mycobacterial Taxonomy: the New Mycobacteria of the 1990s , 2003, Clinical Microbiology Reviews.

[19]  Gilbert Greub,et al.  Amoebal Coculture of “Mycobacterium massiliense” sp. nov. from the Sputum of a Patient with Hemoptoic Pneumonia , 2004, Journal of Clinical Microbiology.

[20]  D. van Soolingen,et al.  Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria. , 2012, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[21]  B. Gicquel,et al.  Mycobacterium abscessus: a new antibiotic nightmare. , 2012, The Journal of antimicrobial chemotherapy.

[22]  Frank,et al.  Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis , 1993, Journal of clinical microbiology.

[23]  M. Morgan,et al.  Multicenter Evaluation of the BACTEC MGIT 960 System for Recovery of Mycobacteria , 1999, Journal of Clinical Microbiology.

[24]  R. Wallace,,et al.  Identification of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulare , 1994, Antimicrobial Agents and Chemotherapy.

[25]  T. Iwamoto,et al.  Clinical and Microbiological Differences between Mycobacterium abscessus and Mycobacterium massiliense Lung Diseases , 2012, Journal of Clinical Microbiology.

[26]  C. Inderlied,et al.  Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease , 1995, Antimicrobial agents and chemotherapy.

[27]  E. Böttger,et al.  The role of ribosomal RNAs in macrolide resistance , 1997, Molecular microbiology.

[28]  S. Chopra,et al.  Identification of antimicrobial activity among FDA-approved drugs for combating Mycobacterium abscessus and Mycobacterium chelonae. , 2011, The Journal of antimicrobial chemotherapy.

[29]  D. Griffith,et al.  Therapy of refractory nontuberculous mycobacterial lung disease , 2012, Current opinion in infectious diseases.

[30]  Didier Raoult,et al.  rpoB gene sequence-based characterization of emerging non-tuberculous mycobacteria with descriptions of Mycobacterium bolletii sp. nov., Mycobacterium phocaicum sp. nov. and Mycobacterium aubagnense sp. nov. , 2006, International journal of systematic and evolutionary microbiology.

[31]  M. Iseman,et al.  The importance of nontuberculous mycobacterial lung disease. , 2008, American journal of respiratory and critical care medicine.

[32]  S. Hobbie,et al.  Phylogenetic Sequence Variations in Bacterial rRNA Affect Species-Specific Susceptibility to Drugs Targeting Protein Synthesis , 2011, Antimicrobial Agents and Chemotherapy.

[33]  T. Shim,et al.  Proportions of Mycobacterium massiliense and Mycobacterium bolletii Strains among Korean Mycobacterium chelonae-Mycobacterium abscessus Group Isolates , 2008, Journal of Clinical Microbiology.